These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prolonged immunosuppression does not improve risk of sensitization or likelihood of retransplantation after kidney transplant graft failure. Martin K; Cantwell L; Barraclough KA; Lian M; Masterson R; Hughes PD; Chow KV Transpl Int; 2021 Nov; 34(11):2353-2362. PubMed ID: 34320262 [TBL] [Abstract][Full Text] [Related]
6. The Role of Allograft Nephrectomy in the Failing Kidney Transplant. Budhiraja P; Nguyen M; Heilman R; Kaplan B Transplantation; 2023 Dec; 107(12):2486-2496. PubMed ID: 37122077 [TBL] [Abstract][Full Text] [Related]
12. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244 [TBL] [Abstract][Full Text] [Related]
13. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality. Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147 [TBL] [Abstract][Full Text] [Related]
14. Review: Management of patients with kidney allograft failure. Bunthof KLW; Hazzan M; Hilbrands LB Transplant Rev (Orlando); 2018 Jul; 32(3):178-186. PubMed ID: 29628415 [TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? Höcker B; Tönshoff B Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600 [TBL] [Abstract][Full Text] [Related]
16. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis. Rodríguez-Perálvarez M; Guerrero-Misas M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011639. PubMed ID: 28362060 [TBL] [Abstract][Full Text] [Related]
17. Management considerations in the failing renal allograft. Lea-Henry T; Chacko B Nephrology (Carlton); 2018 Jan; 23(1):12-19. PubMed ID: 28905454 [TBL] [Abstract][Full Text] [Related]
18. A comparison of mycophenolate mofetil and calcineurin inhibitor as maintenance immunosuppression for kidney transplant recipients: A meta-analysis of randomized controlled trials. Deng J; Lu Y; He L; Ou J; Xie H Turk J Med Sci; 2021 Jun; 51(3):1080-1091. PubMed ID: 33356028 [TBL] [Abstract][Full Text] [Related]
19. Sensitization trends after renal allograft failure: the role of DQ eplet mismatches in becoming highly sensitized. Singh P; Filippone EJ; Colombe BW; Shah AP; Zhan T; Harach M; Gorn C; Frank AM Clin Transplant; 2016 Jan; 30(1):71-80. PubMed ID: 26529289 [TBL] [Abstract][Full Text] [Related]
20. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Hong T; Zhang M; Fan J Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]